Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel
David G. Birch, Janet K. Cheetham, Stephen P. Daiger, et al.
Translational Vision Science & Technology (2023) Vol. 12, Iss. 6, pp. 5-5
Open Access | Times Cited: 11

Showing 11 citing articles:

Pre-Clinical and Clinical Advances in Gene Therapy of X-Linked Retinitis Pigmentosa: Hope on the Horizon
Nadezhda A. Pechnikova, M. Poimenidou, Ioannis V. Iliadis, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 898-898
Open Access
Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review
Chulpan B. Kharisova, Kristina V. Kitaeva, Valeriya V. Solovyeva, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 365-365
Open Access
Characterization of Visual Field Loss Over 4 Years in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study
Jacque L. Duncan, Maureen G. Maguire, Lee S. McDaniel, et al.
American Journal of Ophthalmology (2025)
Closed Access
Clinical Pharmacology Perspective on Development of Adeno‐Associated Virus Vector‐Based Retina Gene Therapy
Jennifer Lynn Ford, Eleni Karatza, Hardik Mody, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 6, pp. 1212-1232
Open Access | Times Cited: 4
Update on Clinical Trial Endpoints in Gene Therapy Trials for Inherited Retinal Diseases
J. Igoe, Byron L. Lam, Ninel Z. Gregori
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5512-5512
Open Access | Times Cited: 3
Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs
John S. Duncan, Angela Bowman, Amy Laster, et al.
Translational Vision Science & Technology (2024) Vol. 13, Iss. 12, pp. 28-28
Open Access | Times Cited: 1
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey
Katalin Pungor, Jennifer Lee, Tom Denee, et al.
Advances in Therapy (2024) Vol. 41, Iss. 8, pp. 3378-3395
Open Access | Times Cited: 1
Establishing Clinical Trial Endpoints in Selecting Patients for RPGR Retinal Gene Therapy
Evita Evangelia Christou, Amandeep S. Josan, Jasmina Cehajic‐Kapetanovic, et al.
Translational Vision Science & Technology (2024) Vol. 13, Iss. 9, pp. 18-18
Open Access | Times Cited: 1
XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants With RPGR-associated X-Linked Retinitis Pigmentosa
Robert E. MacLaren, Jacque L. Duncan, M. Dominik Fischer, et al.
Ophthalmology Science (2024) Vol. 5, Iss. 1, pp. 100595-100595
Closed Access
Deep learning aided measurement of outer retinal layer metrics as biomarkers for inherited retinal degenerations: opportunities and challenges
Mark E. Pennesi, Yi-Zhong Wang, David G. Birch
Current Opinion in Ophthalmology (2024)
Closed Access
Review research designed to investigate gene function and possible impact of specific variants
Moyra Smith
Elsevier eBooks (2024), pp. 315-353
Closed Access
Page 1

Scroll to top